Success Metrics

Clinical Success Rate

100.0%

Based on 1 completed trials

Completion Rate

100%(1/1)

Active Trials

3(50%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

50%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

N/ANon-phased studies

3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(3)

Completed(1)

Terminated(1)

Other(1)

Detailed Status

Active, not recruiting3

Withdrawn1

unknown1

Completed1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

active_not_recruiting350%

withdrawn117%

unknown117%

completed117%

Recent Activity

3 active trials

Showing 5 of 6

active_not_recruitingnot_applicable

Pilot Study of 18F-FAZA in Assessing Early Functional Response in Patients With Inoperable Non Small Cell Lung Cancer Undergoing Radiotherapy or Chemo-radiotherapy

NCT00765986

View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials

NCT03418818Not Applicable

FAZA PET/MRI Sarcoma

Active Not Recruiting

NCT02701699Not Applicable

18F-Fluoroazomycin Arabinoside (18F-FAZA) in Lung Cancer

Active Not Recruiting

NCT04395469Not Applicable

FAZA PET/MRI Pancreas

Active Not Recruiting

NCT00756691

A Radiopharmacokinetic and Radiodosimetric Phase I Imaging Study of 18F-FAZA

Withdrawn

NCT00765986

Pilot Study of 18F-FAZA in Assessing Early Functional Response in Patients With Inoperable Non Small Cell Lung Cancer Undergoing Radiotherapy or Chemo-radiotherapy

Unknown

NCT01017224

DAHANCA 24: Prognostic Value of 18F-FAZA in Head and Neck Squamous Cell Carcinoma (HNSCC)

Completed

All 6 trials loaded

Drug Details

Intervention Type: BIOLOGICAL
Total Trials: 6